In light of the above information, considering the role of platelets, white blood cells and their subtypes, lipids, CRP, and albumin in neuroinflammation, neurodegeneration, and cognitive decline, it can be said that the presence of these parameters outside the brain makes them an accessible and promising therapeutic target for AD. The gene discussed is CRP; the disease is Alzheimer disease.